PortfoliosLab logo

Agios Pharmaceuticals, Inc. (AGIO)

Equity · Currency in USD · Last updated Aug 6, 2022

Company Info

ISINUS00847X1046
CUSIP00847X104
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$29.74
Year Range$17.06 - $49.78
EMA (50)$22.71
EMA (200)$29.96
Average Volume$741.51K
Market Capitalization$1.57B

AGIOShare Price Chart


Chart placeholderClick Calculate to get results

AGIOPerformance

The chart shows the growth of $10,000 invested in Agios Pharmaceuticals, Inc. in Jul 2013 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $9,508 for a total return of roughly -4.92%. All prices are adjusted for splits and dividends.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%MarchAprilMayJuneJulyAugust
-7.03%
-9.63%
AGIO (Agios Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AGIOReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M16.86%8.19%
6M2.94%-7.42%
YTD-9.52%-13.03%
1Y-36.11%-5.85%
5Y-13.52%10.86%
10Y-0.56%10.48%

AGIOMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-6.02%0.78%-6.49%-24.53%-11.38%13.87%-2.71%37.88%
20218.40%1.00%8.85%8.06%-0.04%-1.20%-12.74%-7.09%3.29%1.84%-24.21%-7.72%
20202.05%-2.57%-25.27%15.95%25.77%3.36%-15.26%-9.51%-14.65%14.49%15.60%-6.46%
201916.24%21.03%3.96%-17.08%-17.44%8.04%-3.55%-21.12%-14.62%-7.16%29.32%22.75%
201837.76%2.07%1.73%2.60%11.43%-9.91%2.59%-6.58%-4.46%-18.23%4.35%-29.92%
20173.12%12.57%20.56%-14.88%-6.12%10.24%8.73%13.09%5.52%-3.72%-4.23%-7.12%
2016-34.97%-9.17%5.87%20.57%14.30%-25.12%7.96%-18.55%43.38%-9.43%21.68%-28.31%
20153.46%-7.45%-12.10%-2.08%32.14%-8.92%-0.86%-21.58%-18.30%3.22%-11.35%0.51%
201410.44%18.19%25.24%7.43%-16.41%30.32%-12.05%14.69%32.73%36.97%19.97%11.14%
2013-6.78%-19.14%18.58%-17.17%-24.22%36.47%

AGIOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Agios Pharmaceuticals, Inc. Sharpe ratio is -0.60. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.50-1.00-0.500.000.501.00MarchAprilMayJuneJulyAugust
-0.60
-0.31
AGIO (Agios Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AGIODividend History


Agios Pharmaceuticals, Inc. doesn't pay dividends

AGIODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-77.97%
-13.58%
AGIO (Agios Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AGIOWorst Drawdowns

The table below shows the maximum drawdowns of the Agios Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Agios Pharmaceuticals, Inc. is 87.36%, recorded on Jun 14, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-87.36%Jan 15, 20151867Jun 14, 2022
-51.6%Oct 7, 201336Nov 25, 201333Jan 14, 201469
-38.02%Jan 16, 201412Feb 3, 201423Mar 7, 201435
-34.2%Apr 10, 201428May 20, 201422Jun 20, 201450
-32.91%Jun 23, 201418Jul 17, 201448Sep 24, 201466
-30.88%Aug 15, 20139Aug 27, 201327Oct 4, 201336
-24.78%Mar 11, 201418Apr 3, 20143Apr 8, 201421
-14.59%Oct 31, 20146Nov 7, 20143Nov 12, 20149
-11.23%Dec 23, 20141Dec 23, 201410Jan 8, 201511
-11.19%Jul 25, 20131Jul 25, 201313Aug 13, 201314

AGIOVolatility Chart

Current Agios Pharmaceuticals, Inc. volatility is 91.75%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%MarchAprilMayJuneJulyAugust
91.75%
19.67%
AGIO (Agios Pharmaceuticals, Inc.)
Benchmark (^GSPC)